Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia

Journal of Neurosurgery

Volumn 85, Issue 1, 1996, Pages 117-124

  Marinov, Marin B ^a   Harbaugh, Kimberly S ^a   Hoopes, P Jack ^a   Pikus, Harold J ^a   Harbaugh, Robert E ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

cerebral ischemia; cerebral protection; cerebrovascular surgery; magnesium; N methyl D aspartate receptor antagonists

Indexed keywords

MAGNESIUM SULFATE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; TISSUE SECTION;

EID: 0029991515     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.1.0117     Document Type: Article

References (58)

1. 2+ in isolated human cerebral arteries. Eur J Pharmacol 229:83-89, 1992
2. Altura BT, Altura BM: Interaction of Mg and K on cerebral vessels - aspects in view of stroke. Review of present status and new findings. Magnesium 3:195-211, 1984
3. Ames A III, Maynard KI, Kaplan S: Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J Cereb Blood Flow Metab 15:433-439, 1995
4. Back T, Ginsberg MD, Zhao W: Three-dimensional reconstruction of local brain glucose metabolism/blood flow uncoupling in the ischemic penumbra of brain infarcts: correlation with electrophysiology. J Cereb Blood Flow Metab 15 (Suppl 1): S13, 1995 (Abstract)
5. Bederson JB, Fitts LH, Tsuji M, et al: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986
6. Belfort MA, Moise KJ Jr: Effects of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 167:661-666, 1992
7. Blair JL, Warner DS, Todd MM: Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats. Stroke 20:507-512, 1989
8. Casscells W: Magnesium and myocardial infarction. Lancet 343:807-809, 1994
9. Chi OZ, Pollak P, Weiss HR: Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 304:196-205, 1990
10. Choi DW: Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurol Sci 11:465-469, 1988
11. Chopp M, Zhang RL, Chen H, et al: Postischemic administration of an Anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25:869-875, 1994
12. de Courten-Myers GM, Myers RE, Schoolfield L: Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 19:623-630, 1988
13. DeGraba TJ, Ostrow PT, Grotta JC: Threshold of calcium disturbances after focal cerebral ischemia in rats. Implications of the window of therapeutic opportunity. Stroke 24:1212-1217, 1993
14. Garcia JH, Yoshida Y, Chen H, et al: Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 142:623-635, 1993
15. Ginsberg MD: Neuroprotection in brain ischemia: an update (part 1). Neuroscientist 1:95-103, 1995
16. Ginsberg MD, Pulsinelli WA: The ischemic penumbra, injury thresholds and the therapeutic window for acute stroke. Ann Neurol 36:553-554, 1994
17. Hamilton MG, Tranmer BI, Auer RN: Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 82:262-268, 1995
18. Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36:557-565, 1994
19. Huang QF, Gebrewold A, Zhang A, et al: Role of excitatory amino acids in regulation of rat pial microvasculature. Am J Physiol 266:R158-R163, 1994
20. Iseri LT, French JH: Magnesium: nature's physiologic calcium blocker. Am Heart J 108:188-193, 1984
21. Izumi Y, Roussel S, Pinard E, et al: Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 11:1025-1030, 1991
22. Kaplan B, Brint S, Tanabe J, et al: Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 22:1032-1039, 1991
23. Kass IS, Cottrell JE, Chambers G: Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hyppocampal slice. Anesthesiology 69:710-715, 1988
24. G-nitro-L-arginine methyl esther, in conscious rats. Clin Sci 85: 175-181, 1993
25. Koizumi J, Yoshida Y, Nakazawa T, et al: Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats, in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8:1-8, 1986 [Reference unverified]
26. König JFR, Klippel RA: The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Baltimore: Williams & Wilkins, 1963
27. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622, 1994
28. Marinov M, Wassmann H, Natschev S: Effect of nimodipine in treatment of experimental focal cerebral ischaemia. Neurol Res 13:77-83, 1991
29. 2+ of NMDA responses in spinal cord neurones. Nature 309:261-263, 1984 (Letter)
30. McIntosh TK, Vink R, Yamakami I, et al: Magnesium protects against neurological deficit after brain injury. Brain Res 482: 252-260, 1989
31. McLean RM: Magnesium and its therapeutical uses: a review. Am J Med 96:63-76, 1994
32. Memezawa H, Smith ML, Siesjö BK: Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23:552-559, 1992
33. Muir KW, Lees KR: Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513, 1995
34. Muir KW, Lees KR: A randomized, double blind, placebo-controlled pilot trial of intravenous magnesium sulphate in acute stroke. Stroke 26:1183-1188, 1995
35. Nedergaard M: Mechanisms of brain damage in focal cerebral ischemia. Acta Neurol Scand 77:81-101, 1988
36. Nishiki T, Yoshioka H, Mitsufuji N, et al: The effects of magnesium administration on ischemic brain injury in neonatal rats. J Cereb Blood Flow Metabol 15 (Suppl 1):S285, 1995 (Abstract)
37. Nishio A, Gebrewold A, Altura BT, et al: Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: an in situ study on microcirculation. J Pharmacol Exp Ther 246:859-865, 1988
38. Nowak L, Bregestovski P, Ascher P: Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462-465, 1984
39. Oppelt WW, MacIntyre I, Rall DP: Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 205: 959-962, 1963
40. Pulsinelli W: Pathophysiology of acute ischaemic stroke. Lancet 339:533-536, 1992
41. Ram Z, Sadeh M, Shacked I, et al: Magnesium sulphate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922-927, 1991
42. Rothman S: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4: 1884-1891, 1984
43. Rothman SM: Synaptic activity mediates death of hypoxic neurons. Science 220:536-537, 1983
44. Sadeh M: Action of magnesium sulphate in the treatment of preeclampsia-eclampsia. Stroke 20:1273-1275, 1989
45. 31P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta 1158:257-263, 1993
46. Selman WR, Crumrine RC, Ricci AJ, et al: Impairment of metabolic recovery with increasing periods of middle cerebral artery occlusion in rats. Stroke 21:467-471, 1990
47. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 77:169-184, 1992
48. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992
49. Sjostrom LG, Wester P: Systemically induced hypermagnesemia increases the bioavailability of magnesium in rat brain. Soc Neurosci 20 (Part I):181, 1994 (Abstract)
50. Slivka A, Murphy E, Horrocks L: Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke 26:1061-1066, 1995
51. Swanson RA, Morton MT, Tsao-Wu G, et al: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293, 1990
52. Thordstein M, Bågenholm R, Thiringer K, et al: Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat. Pediatr Res 34:23-26, 1993
53. Thurnau GR, Kemp DB, Jarris A: Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 157:1435-1438, 1987
54. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience 44:335-341, 1991
55. ++ protect against irreversible damage during CNS ischemia. Stroke 15: 695-698, 1984
56. Wallach S: Physiologic and critical interrelations of hormones and magnesium. Consideration of thyroid, insulin, corticosteroids, sex steroids, and catecholamines, in Cantin M, Seelig MS (eds): Magnesium in Health and Disease, Second International Symposium on Magnesium. Jamaica, NY: Spectrum, 1980, pp 241-258
57. Wolf G, Keilhoff G, Fischer S. et al: Subcutaneously applied magnesium protects reliably against quinolinate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: are there therapeutical implications? Neurosci Lett 117:207-211, 1990
58. Zea Longa E, Weinstein PR, Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989